Micardis HCT 80-25 MG tablet UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6U6P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,433
Award facts
- Contract value 100% obligated
- $1,432.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging of 30 units. This contract was competitively awarded without any set-aside designation and carries a ceiling value of $1,432.55 under a firm fixed-price delivery order arrangement. The award concludes on December 12, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Pennsylvania, maintains a significant federal contract portfolio focused on supplying medications and medical supplies to military and veteran healthcare systems. The company's federal awards demonstrate extensive experience delivering across multiple therapeutic domains, including brand-name and generic medications, vaccines, and specialized medical devices. This particular delivery order for Micardis HCT, a hypertension medication, exemplifies the company's role in supporting the Defense Health Agency's pharmaceutical procurement requirements through the DLA's Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F6U6P?
SPE2DR26F6U6P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F6U6P worth?
The government has obligated $1,433 on SPE2DR26F6U6P.
Is contract SPE2DR26F6U6P an order under another contract?
Yes. SPE2DR26F6U6P is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6U6P competed?
The extent of competition for SPE2DR26F6U6P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award